Mathias Lichterfeld is an Infectious Disease physician. ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Telephone
617-724-6620Registry record last updated 15 Feb 2011.
Clinical trials
- Dual bNAb Treatment in Children
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy
Sponsor: Massachusetts General Hospital
- Early Infant HIV Treatment in Botswana
Sponsor: Harvard School of Public Health (HSPH)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202510 payments$10,082openpaymentsdata.cms.gov ↗
- ViiV Healthcare CompanyProgram year20251 payment
- ViiV Healthcare CompanyProgram year20247 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
18 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Single-cell Proteogenomic profiling of HIV-1 reservoir cells
Massachusetts General Hospital
FY2026$1,313,603R01AI176579 - A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
Harvard University D/b/a Harvard School of Public Health
FY2026$1,112,870U01AI179561 - A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
Harvard University D/b/a Harvard School of Public Health
FY2026$1,037,835U01AI179561
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”